Stanton Glantz

Professor of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Stanton Glantz is a retired Professor of Medicine at the University of California San Francisco, United States. His research focuses on the health impacts of tobacco and cannabis use, including their implications for cardiovascular disease and public health. He has published extensively on topics such as the effects of electronic cigarettes, cannabis legalization, and the tactics of the tobacco industry in education and harm reduction.

Articles (18)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (3)

Stella Bialous

Professor

University of California, San Francisco

UNITED STATES

View details

Reiner Hanewinkel

GERMANY

View details

Heikki Hiilamo

University of Helsinki

FINLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Stanton Glantz

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

It is time to treat cannabis as an important risk factor for cardiovascular disease

Historical and political context for Philip Morris International’s continuing medical education courses on harm reduction

Clinical trial shows that giving smokers free e-cigarettes creates more dual users than switchers or quitters

Cannabis legalization and changes in cannabis and tobacco/nicotine use and co-use in a national cohort of U.S. adults during 2017–2021

Are Fourth-Generation e-Cigarettes Reducing Disease in the Population?

More than a “characterizing flavor”: Menthol at subliminal levels in tobacco products

Awareness of tobacco industry tactics among tobacco control communities in Thailand and its association with attitudes towards tobacco industry and perceptions of e-cigarettes

Association of Cannabis Use With Cardiovascular Outcomes Among US Adults

Smoking and healthcare expenditure reductions associated with the California Tobacco Control Program, 1989 to 2019: A predictive validation

e-Cigarettes Used by Adolescents to Try to Quit Smoking Are Associated With Less Quitting: A Cross-Sectional Analysis of the National Youth Tobacco Survey

Vuse Solo e-cigarettes do not provide net benefits to public health: a scientific analysis of FDA’s marketing authorisation

Active Smokers Are at Higher Risk of COVID-19 Death: A Systematic Review and Meta-analysis

Longitudinal bidirectional association between youth electronic cigarette use and tobacco cigarette smoking initiation in Thailand

Appropriate Policy Implications of the Fact That High Content and Flavored E-Cigarettes Have Higher Abuse Liability

FDA’s reduced exposure marketing order for IQOS: why it is not a reliable global model

Securing Smokefree Laws Covering Casinos and Bars in Louisiana via Messaging, Continuous Campaigning and Health Coalitions

Global Implementation of Tobacco Demand Reduction Measures Specified in Framework Convention on Tobacco Control

The Perils of Drawing Strong Conclusions Based on Underpowered Analyses

Collaborators (3)

Stella Bialous

Reiner Hanewinkel

Heikki Hiilamo

Make your next move.